Related Experiment Video

Updated: May 1, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.5K

DNA methylation and apoptosis resistance in cancer cells

Eric Hervouet1, Mathilde Cheray2, François Marie Vallette3

  • 1Laboratoire de Biochimie, EA3922, UFR-ST, Université de Franche-Comté, 25035 Besançon Cedex, France. eric.hervouet@univ-fcomte.fr.

Cells
|April 9, 2014
PubMed

Insights

Apoptosis, a programmed cell death, is crucial for health. Aberrant DNA methylation of apoptosis-related genes can cause cancer cells to resist cell death, driving disease progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Biology

Background:

  • Apoptosis is a vital programmed cell death process essential for maintaining cellular homeostasis.
  • Dysregulation of apoptosis contributes to various human diseases, notably cancer.
  • Cancer cells often exhibit resistance to apoptosis, a key hallmark of malignancy.

Purpose of the Study:

  • To review the role of DNA methylation in apoptosis-related genes.
  • To highlight how aberrant DNA methylation contributes to cancer cell resistance to apoptosis.
  • To explore potential therapeutic strategies targeting DNA methylation in cancer.

Main Methods:

  • Literature review focusing on DNA methylation and apoptosis in cancer.
  • Analysis of mechanisms underlying cancer cell apoptosis resistance.
  • Synthesis of current research on DNA methylation patterns in apoptosis-related genes.

Main Results:

  • Cancer cells develop resistance to apoptosis through various mechanisms, including genetic mutations and altered protein expression.
  • Aberrant DNA methylation, both hypermethylation and hypomethylation, of genes involved in apoptosis is a significant factor in cancer cell resistance.
  • Specific DNA methylation patterns can silence pro-apoptotic genes or activate anti-apoptotic pathways, promoting cancer survival.

Conclusions:

  • DNA methylation plays a critical role in regulating apoptosis-related genes in cancer.
  • Aberrant DNA methylation patterns are implicated in the development and progression of cancer by conferring apoptosis resistance.
  • Targeting DNA methylation of apoptosis-related genes presents a promising therapeutic avenue for cancer treatment.

More Related Videos

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution13:47

Enhanced Reduced Representation Bisulfite Sequencing for Assessment of DNA Methylation at Base Pair Resolution

Published on: February 24, 2015

27.3K
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

10.4K

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.5K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K